Patents by Inventor Zaid A. Abassi

Zaid A. Abassi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR AMELIORATING RENAL DYSFUNCTION INDUCED BY RENAL HYPOPERFUSION OR ACUTE KIDNEY INJURY
    Publication number: 20130296331
    Abstract: The invention provides compositions and methods for ameliorating renal dysfunction induced by renal hypoperfusion or acute kidney injury, resulting for example from increased intra-abdominal pressure, using phosphodiesterase inhibitors, more particularly phosphodiesterase type inhibitors, or pharmaceutically acceptable salts or solvates thereof.
    Type: Application
    Filed: November 24, 2011
    Publication date: November 7, 2013
    Applicant: Technion Research and Development Foundation Ltd.
    Inventors: Zaid Abassi, Bishar Bishara
  • Apparatus and methods for diagnosing renal disorders
    Patent number: 8481324
    Abstract: The present invention provides a system containing an array of chemically sensitive sensors based on coated single walled carbon nanotubes, for measuring volatile organic compounds indicative of renal failure. Methods of breath analysis for diagnosing chronic, acute and end-stage renal failure are disclosed.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: July 9, 2013
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: Hossam Haick, Zaid Abassi, Farid Nakhoul
  • Methods for treatment of renal failure
    Patent number: 8263655
    Abstract: Propargylamine, propargylamine derivatives N-propargyl-1-aminoindan and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for administration to a subject at high risk for or suffering from acute renal failure (ARF).
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: September 11, 2012
    Assignees: Technion Research and Development Foundation Ltd, Rappaport Family Institute
    Inventors: Ofer Binah, Zaid A. Abassi, Moussa B. H. Youdim, Yaron Barac
  • METHODS FOR TREATMENT OF CARDIOVASCULAR DISORDERS AND DISEASES
    Publication number: 20120095107
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-l-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
    Type: Application
    Filed: December 23, 2011
    Publication date: April 19, 2012
    Applicants: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES, TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
    Inventors: Moussa B.H. YOUDIM, Ofer Binah, Zaid A. Abassi, Yaron Barac
  • Methods for treatment of cardiovascular disorders and diseases
    Patent number: 8097608
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: January 17, 2012
    Assignees: Technion Research and Development Foundation Ltd., Rappaport Family Institute
    Inventors: Moussa B. H. Youdim, Ofer Binah, Zaid A. Abassi, Yaron Barac
  • APPARATUS AND METHODS FOR DIAGNOSING RENAL DISORDERS
    Publication number: 20110244584
    Abstract: The present invention provides a system comprising an array of chemically sensitive sensors based on coated single walled carbon nanotubes, for measuring volatile organic compounds indicative of renal failure. Methods of breath analysis for diagnosing chronic, acute and end-stage renal failure are disclosed.
    Type: Application
    Filed: December 2, 2009
    Publication date: October 6, 2011
    Applicant: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
    Inventors: Hossam Haick, Zaid Abassi, Farid Nakhoul
  • Methods for treatment of cardiovascular disorders and diseases
    Patent number: 8008284
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: August 30, 2011
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: Moussa B. H. Youdim, Ofer Binah, Zaid A. Abassi, Yaron Barac
  • METHOD FOR PREVENTING OR ATTENUATING ANTHRACYCLINE-INDUCED CARDIOTOXICITY
    Publication number: 20080090915
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or attenuation of anthracycline-induced cardiotoxicity.
    Type: Application
    Filed: October 18, 2007
    Publication date: April 17, 2008
    Applicants: Technion Research and Development Foundation Ltd., Rappaport Family Institute for Research in the Medical Sciences
    Inventors: Moussa Youdim, Ofer Binah, Zaid Abassi, Yaron Barac
  • Methods for treatment of renal failure
    Publication number: 20070082958
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of renal failure.
    Type: Application
    Filed: October 6, 2005
    Publication date: April 12, 2007
    Applicants: Technion Research and Development Foundation Ltd., Rappaport Family Institute
    Inventors: Ofer Binah, Zaid Abassi, Moussa Youdim
  • Methods for treatment of cardiovascular disorders and diseases
    Publication number: 20060287401
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
    Type: Application
    Filed: June 9, 2006
    Publication date: December 21, 2006
    Applicants: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD., RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
    Inventors: Moussa Youdim, Ofer Binah, Zaid Abassi, Yaron Barac
  • Compositions and methods for treatment of cardiovascular disorders and diseases
    Publication number: 20050171210
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders and diseases.
    Type: Application
    Filed: September 29, 2004
    Publication date: August 4, 2005
    Applicants: Technion Research and Development Foundation Ltd., Rappaport Family Institute For Research In The Medical Sciences
    Inventors: Moussa Youdim, Ofer Binah, Zaid Abassi, Yaron Barac